Catabasis Pharmaceuticals

At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART linker platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.
Type
Public
HQ
Cambridge, US
Founded
2008
Employees
37 (est)
Catabasis Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US

Catabasis Pharmaceuticals Locations

Cambridge, US

Catabasis Pharmaceuticals Metrics

Catabasis Pharmaceuticals Summary

Market capitalization

$63.6 M

Closing share price

$3.46
Catabasis Pharmaceuticals's latest market capitalization is $63.6 M.

Catabasis Pharmaceuticals Market Value History

Catabasis Pharmaceuticals News

Catabasis Pharmaceuticals Company Life

You may also be interested in